Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, focused on delivering innovative therapies in critical care […]
Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia
Kintor Pharmaceutical, a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that […]
Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity
Patient Discovery Solutions, a leader in health equity solutions that harness the power of patient-centered […]
Pavel Dřevínek, an Academic Researcher, on Services for Sepsis
At the 33rd ECCMID event, we caught up with Pavel Dřevínek, an academic researcher at […]
Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology
Bayer and Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics […]
Otsuka and Lundbeck Announce FDA Approval of Supplemental New Drug Application for REXULTI® (brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer’s Disease
Otsuka Pharmaceutical and Lundbeck announce the U.S. Food and Drug Administration (FDA) has approved the supplemental New […]
Healthy.io Announces Collaboration with Boehringer Ingelheim to Increase Access to Testing for Kidney Disease
Healthy.io, the global leader in transforming the smartphone camera into a medical device, today announced […]
David Jenkins, University Hospitals of Leicester, Discussing Antimicrobial Chemotherapy
In the video, David Jenkins, a consultant medical microbiologist from the University Hospitals of Leicester, […]
Maryland Stem Cell Research Commission Announces Over $14 Million in Awards to Accelerate Stem Cell Cures
The Maryland Stem Cell Research Commission is pleased to announce over $14.1 million in grant […]
CytoMed Therapeutics Announces Collaboration with MD Anderson Cancer Center
CytoMed Therapeutics, a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more